Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Net Cash Flow (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Net Cash Flow for 9 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Cash Flow rose 38.42% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.3 million, a 203.78% increase, with the full-year FY2024 number at $8.3 million, up 1098.7% from a year prior.
  • Net Cash Flow was $1.1 million for Q3 2025 at SANUWAVE Health, up from -$5000.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $7.0 million in Q4 2024 to a low of -$1.7 million in Q1 2025.
  • A 3-year average of $761636.4 and a median of $747000.0 in 2023 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: skyrocketed 941.05% in 2024, then crashed 268.87% in 2025.
  • SANUWAVE Health's Net Cash Flow stood at $747000.0 in 2023, then skyrocketed by 834.14% to $7.0 million in 2024, then tumbled by 84.15% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Net Cash Flow are $1.1 million (Q3 2025), -$5000.0 (Q2 2025), and -$1.7 million (Q1 2025).